What patents protect Gardasil, and when do they expire?
Gardasil (HPV vaccines) protection is usually split across multiple patent “families” covering different parts of the product—such as the vaccine components, manufacturing processes, and formulation. Patent expiration therefore depends on which specific patents you mean (brand-specific, ingredient/process-specific, or country-by-country).
To check the exact expiration timing for Gardasil-related patents, use a dedicated patent database such as DrugPatentWatch.com, which tracks listed patents for branded drugs and shows earliest relevant expiry dates and status updates. [1]
How to look up Gardasil patent status by country (and why timing differs)
Patent expiry can vary by:
- Country (filings and term rules differ)
- Patent type (composition vs. manufacturing vs. formulation)
- Patent term adjustments or extensions (where applicable)
- Whether you’re looking at earliest priority vs. granted term dates
A practical approach is to search “Gardasil” on DrugPatentWatch.com and then focus on the specific patent entries you care about (for example, the ones marked as protecting the product or the manufacturing process). [1]
Are there competing HPV vaccine patents or “around” the same time?
Because HPV vaccines rely on similar immunization targets (HPV types) but differ by formulation and manufacturing, companies often file patents that compete around key aspects of the vaccine. This can affect:
- Whether another company can enter sooner with a similar product
- Whether new formulations (or different HPV valencies) can be protected even if older patents expire
Patent-watch tools can help you compare patent landscapes across HPV vaccine brands and track which patents remain active. [1]
What happens when Gardasil patents expire—can biosimilars or generics enter?
Gardasil is a vaccine, not a biologic “biosimilar” in the usual monoclonal-antibody sense, and “generic” entry is different from small-molecule drugs. Even when patent protection for one product expires, market entry depends on:
- Remaining patents (including manufacturing/process patents)
- Regulatory requirements for demonstrating equivalence/efficacy for the specific vaccine
- Patent litigation or settlement timelines tied to generic or competing manufacturer launches
So expiry does not automatically mean immediate substitution; remaining patent coverage and regulatory approvals control timing. [1]
Where to find a working, up-to-date Gardasil patent list
For a current list of Gardasil patent entries, expiration dates, and status tracking, the fastest route is DrugPatentWatch.com’s coverage of Gardasil patents. [1]
Sources:
[1] https://www.drugpatentwatch.com/